Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2.
Journal
Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354
Informations de publication
Date de publication:
09 2022
09 2022
Historique:
received:
10
04
2022
accepted:
18
07
2022
pubmed:
30
8
2022
medline:
20
9
2022
entrez:
29
8
2022
Statut:
ppublish
Résumé
T cells can contribute to clearance of respiratory viruses that cause acute-resolving infections such as SARS-CoV-2, helping to provide long-lived protection against disease. Recent studies have suggested an additional role for T cells in resisting overt infection: pre-existing cross-reactive responses were preferentially enriched in healthcare workers who had abortive infections
Identifiants
pubmed: 36038709
doi: 10.1038/s41590-022-01292-1
pii: 10.1038/s41590-022-01292-1
pmc: PMC9477726
doi:
Substances chimiques
Antibodies, Viral
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1324-1329Subventions
Organisme : Wellcome Trust
ID : 214191/Z/18/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M011569/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : M011569/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 26603
Pays : United Kingdom
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : MRF
ID : MRF_MRF-044-0001-RG-SWADL
Pays : United Kingdom
Informations de copyright
© 2022. The Author(s).
Références
Swadling, L. et al. Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2. Nature 601, 110–117 (2022).
doi: 10.1038/s41586-021-04186-8
Kundu, R. et al. Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts. Nat. Commun. 13, 80 (2022).
doi: 10.1038/s41467-021-27674-x
Zhao, J. et al. Airway memory CD4+ T cells mediate protective immunity against emerging respiratory coronaviruses. Immunity 44, 1379–1391 (2016).
doi: 10.1016/j.immuni.2016.05.006
Loyal, L. et al. Cross-reactive CD4
doi: 10.1126/science.abh1823
Tan, C. C. S. et al. Pre-existing T cell-mediated cross-reactivity to SARS-CoV-2 cannot solely be explained by prior exposure to endemic human coronaviruses. Infect. Genet. Evol. 95, 105075 (2021).
doi: 10.1016/j.meegid.2021.105075
Nesterenko, P. A. et al. HLA-A∗02:01 restricted T cell receptors against the highly conserved SARS-CoV-2 polymerase cross-react with human coronaviruses. Cell Rep. 37, 110167 (2021).
doi: 10.1016/j.celrep.2021.110167
Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501.e15 (2020).
doi: 10.1016/j.cell.2020.05.015
Peng, Y. et al. Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19. Nat. Immunol. 21, 1336–1345 (2020).
doi: 10.1038/s41590-020-0782-6
Bacher, P. et al. Low-avidity CD4+ T cell responses to SARS-CoV-2 in unexposed individuals and humans with severe COVID-19. Immunity 53, 1258–1271.e5 (2020).
doi: 10.1016/j.immuni.2020.11.016
Sekine, T. et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell 183, 158–168.e14 (2020).
doi: 10.1016/j.cell.2020.08.017
Ge, C. et al. Bystander activation of pulmonary Trm cells attenuates the severity of bacterial pneumonia by enhancing neutrophil recruitment. Cell Rep. 29, 4236–4244.e3 (2019).
doi: 10.1016/j.celrep.2019.11.103
Snyder, M. E. & Farber, D. L. Human lung tissue resident memory T cells in health and disease. Curr. Opin. Immunol. 59, 101–108 (2019).
doi: 10.1016/j.coi.2019.05.011
Guvenel, A. et al. Epitope-specific airway-resident CD4+ T cell dynamics during experimental human RSV infection. J. Clin. Invest. 130, 523–538 (2019).
doi: 10.1172/JCI131696
Almeida, S. T., Paulo, A. C., Froes, F., de Lencastre, H. & Sá-Leão, R. Dynamics of pneumococcal carriage in adults: a new look at an old paradigm. J. Infect. Dis. 223, 1590–1600 (2021).
doi: 10.1093/infdis/jiaa558
Carniel, B. F. et al. Pneumococcal colonization impairs mucosal immune responses to live attenuated influenza vaccine in adults. JCI Insight 6, e141088 (2021).
Chung, H., Kim, E.-A. & Chang, J. A ‘prime and deploy’ strategy for universal influenza vaccine targeting nucleoprotein induces lung-resident memory CD8 T cells. Immune Netw. 21, e28 (2021).
doi: 10.4110/in.2021.21.e28
Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T Cells in COVID-19. Cell 183, 1340–1353.e16 (2020).
doi: 10.1016/j.cell.2020.10.001
Killingley, B. et al. Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge in young adults. Nat. Med. 28, 1031–1041 (2022).
doi: 10.1038/s41591-022-01780-9
Gallais, F. et al. Intrafamilial exposure to SARS-CoV-2 associated with cellular immune response without seroconversion, France. Emerg. Infect. Dis. 27, 113–121 (2021).
doi: 10.3201/eid2701.203611
Oxford Immunology Network Covid-19 Response T Cell Consortium et al. T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses. Nat. Commun. 12, 2055 (2021).
doi: 10.1038/s41467-021-21856-3
da Silva Antunes, R. et al. Differential T-cell reactivity to endemic coronaviruses and SARS-CoV-2 in community and health care workers. J. Infect. Dis. 224, 70–80 (2021).
doi: 10.1093/infdis/jiab176
Fonseca, R. et al. Developmental plasticity allows outside-in immune responses by resident memory T cells. Nat. Immunol. 21, 412–421 (2020).
doi: 10.1038/s41590-020-0607-7
Behr, F. M. et al. Tissue-resident memory CD8+ T cells shape local and systemic secondary T cell responses. Nat. Immunol. 21, 1070–1081 (2020).
doi: 10.1038/s41590-020-0723-4
McMaster, S. R., Wilson, J. J., Wang, H. & Kohlmeier, J. E. Airway-resident memory CD8 T cells provide antigen-specific protection against respiratory virus challenge through rapid IFN-γ production. J. Immunol. 195, 203–209 (2015).
doi: 10.4049/jimmunol.1402975
Wein, A. N. et al. CXCR6 regulates localization of tissue-resident memory CD8 T cells to the airways. J. Exp. Med. 216, 2748–2762 (2019).
doi: 10.1084/jem.20181308
Takamura, S. et al. Interstitial-resident memory CD8+ T cells sustain frontline epithelial memory in the lung. J. Exp. Med. 216, 2736–2747 (2019).
doi: 10.1084/jem.20190557
Zheng, M. Z. M. & Wakim, L. M. Tissue resident memory T cells in the respiratory tract. Mucosal Immunol. 15, 379–388 (2021).
doi: 10.1038/s41385-021-00461-z
Pallett, L. J. et al. Longevity and replenishment of human liver-resident memory T cells and mononuclear phagocytes. J. Exp. Med. 217, e20200050 (2020).
doi: 10.1084/jem.20200050
Snyder, M. E. et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Sci. Immunol. 4, eaav5581 (2019).
doi: 10.1126/sciimmunol.aav5581
Slütter, B. et al. Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Sci. Immunol. 2, eaag2031 (2017).
doi: 10.1126/sciimmunol.aag2031
Niessl, J. et al. Identification of resident memory CD8
doi: 10.1126/sciimmunol.abk0894
Roukens, A. H. E. et al. Prolonged activation of nasal immune cell populations and development of tissue-resident SARS-CoV-2-specific CD8+ T cell responses following COVID-19. Nat. Immunol. 23, 23–32 (2022).
doi: 10.1038/s41590-021-01095-w
Grau-Expósito, J. et al. Peripheral and lung resident memory T cell responses against SARS-CoV-2. Nat. Commun. 12, 3010 (2021).
doi: 10.1038/s41467-021-23333-3
Poon, M. M. L. et al. SARS-CoV-2 infection generates tissue-localized immunological memory in humans. Sci. Immunol. 6, eabl9105 (2021).
doi: 10.1126/sciimmunol.abl9105
Afkhami, S. et al. Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2. Cell 185, 896–915.e19 (2022).
doi: 10.1016/j.cell.2022.02.005
Mitsi, E. et al. Nasal pneumococcal density is associated with microaspiration and heightened human alveolar macrophage responsiveness to bacterial pathogens. Am. J. Respir. Crit. Care Med. 201, 335–347 (2020).
doi: 10.1164/rccm.201903-0607OC
Collins, A. M. et al. First human challenge testing of a pneumococcal vaccine. double-blind randomized controlled trial. Am. J. Respir. Crit. Care Med. 192, 853–858 (2015).
doi: 10.1164/rccm.201503-0542OC
Zaidi, S. R. et al. Single use and conventional bronchoscopes for broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591). BMC Pulm. Med. 17, 83 (2017).
doi: 10.1186/s12890-017-0421-7
Le Bert, N. et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature 584, 457–462 (2020).
doi: 10.1038/s41586-020-2550-z
Johnson, M. et al. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2. J. Clin. Virol. 130, 104572 (2020).
doi: 10.1016/j.jcv.2020.104572
de Steenhuijsen Piters, W. A. A. et al. Interaction between the nasal microbiota and S. pneumoniae in the context of live-attenuated influenza vaccine. Nat. Commun. 10, 2981 (2019).
doi: 10.1038/s41467-019-10814-9